Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lenz

Showing results (311-320 of 367) with videos related to

Pageof 37
Sort By:
Cancer Chemotherapy and Pharmacology|January 10, 2021
A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumorsJacob S Thomas, Anthony B El-Khoueiry, Barry J Maurer, et al.
The Pharmacogenomics Journal|December 10, 2014
Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancerP Bohanes, D Yang, F Loupakis, et al.
Oncogene|June 10, 2014
KSR1 regulates BRCA1 degradation and inhibits breast cancer growthJ Stebbing, H Zhang, Y Xu, et al.
Oncogene|April 23, 2021
Correction to: KSR1 regulates BRCA1 degradation and inhibits breast cancer growthJ Stebbing, H Zhang, Y Xu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2013
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trialM A Gordon, H M Gundacker, J Benedetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2009
Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinomaG Lurje, H Husain, D G Power, et al.
The Pharmacogenomics Journal|July 30, 2014
Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancerN B Volz, S Stintzing, W Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2015
Variations in genes involved in dormancy associated with outcome in patients with resected colorectal liver metastasesS Stremitzer, W Zhang, D Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapyR Metzger, C G Leichman, K D Danenberg, et al.
The Pharmacogenomics Journal|June 6, 2012
Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (vatalanib)P M Wilson, D Yang, M Azuma, et al.
Pageof 37

Showing results (311-320 of 367) with videos related to

Sort By:
Pageof 37
Cancer Chemotherapy and Pharmacology|January 10, 2021
A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumorsJacob S Thomas, Anthony B El-Khoueiry, Barry J Maurer, et al.
The Pharmacogenomics Journal|December 10, 2014
Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancerP Bohanes, D Yang, F Loupakis, et al.
Oncogene|June 10, 2014
KSR1 regulates BRCA1 degradation and inhibits breast cancer growthJ Stebbing, H Zhang, Y Xu, et al.
Oncogene|April 23, 2021
Correction to: KSR1 regulates BRCA1 degradation and inhibits breast cancer growthJ Stebbing, H Zhang, Y Xu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2013
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trialM A Gordon, H M Gundacker, J Benedetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2009
Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinomaG Lurje, H Husain, D G Power, et al.
The Pharmacogenomics Journal|July 30, 2014
Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancerN B Volz, S Stintzing, W Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2015
Variations in genes involved in dormancy associated with outcome in patients with resected colorectal liver metastasesS Stremitzer, W Zhang, D Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapyR Metzger, C G Leichman, K D Danenberg, et al.
The Pharmacogenomics Journal|June 6, 2012
Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (vatalanib)P M Wilson, D Yang, M Azuma, et al.
Pageof 37